Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8806 |
High Similarity |
NPD8166 |
Discontinued |
0.8615 |
High Similarity |
NPD6663 |
Approved |
0.8594 |
High Similarity |
NPD5736 |
Approved |
0.8258 |
Intermediate Similarity |
NPD3764 |
Approved |
0.8254 |
Intermediate Similarity |
NPD3019 |
Approved |
0.8129 |
Intermediate Similarity |
NPD7003 |
Approved |
0.811 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7972 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7953 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7926 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7872 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.781 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7801 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5951 |
Approved |
0.777 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7769 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7769 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7752 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7752 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7746 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7724 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7721 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7721 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7686 |
Intermediate Similarity |
NPD5909 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7638 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7609 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7609 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7561 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7538 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7519 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7519 |
Intermediate Similarity |
NPD3972 |
Approved |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7481 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7481 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7481 |
Intermediate Similarity |
NPD5585 |
Approved |
0.748 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7465 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7465 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7465 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7465 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7464 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7447 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7444 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7444 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7426 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7424 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD3095 |
Discontinued |
0.7422 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7397 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7397 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7395 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7395 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7388 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7388 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7361 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD1358 |
Approved |
0.736 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7348 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7338 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD7910 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6647 |
Phase 2 |
0.7313 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7311 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7311 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7302 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD4059 |
Approved |
0.7293 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7241 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7596 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD6677 |
Suspended |
0.7237 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7226 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7214 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD2066 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7206 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7177 |
Intermediate Similarity |
NPD1930 |
Approved |
0.7177 |
Intermediate Similarity |
NPD1929 |
Approved |
0.7177 |
Intermediate Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD255 |
Approved |
0.7176 |
Intermediate Similarity |
NPD256 |
Approved |
0.7174 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7164 |
Intermediate Similarity |
NPD17 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7132 |
Intermediate Similarity |
NPD6124 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD825 |
Approved |
0.7113 |
Intermediate Similarity |
NPD826 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD1809 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD5122 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD37 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1238 |
Approved |
0.707 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6800 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4965 |
Approved |
0.705 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7042 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7031 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7031 |
Intermediate Similarity |
NPD74 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7023 |
Intermediate Similarity |
NPD7159 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7014 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4208 |
Discontinued |
0.6993 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD1240 |
Approved |
0.6992
|
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |